DeJesus, E., Haas, B., Segal-Mauer, S., Ramgopal, M., Mills, A., Margot, N., … McCallister, S. (2018). Superior Efficacy and Improved Renal and Bone Safety After Switching From a Tenofovir Disoproxil Fumarate (TDF)- to a Tenofovir Alafenamide (TAF)-based Regimen Through 96 Weeks of Treatment. AIDS Research and Human Retroviruses. https://doi.org/10.1089/AID.2017.0203 (Original work published 2018)